Clinical Pharmacokinetics of Oral Contraceptive Steroids
暂无分享,去创建一个
A. Breckenridge | D. Back | D J Back | M. Orme | M L Orme | A M Breckenridge | Da-Ae Back
[1] V. Odlind,et al. Free norethisterone as reflected by saliva concentrations of norethisterone during oral contraceptive use. , 1981, Acta endocrinologica.
[2] H. Adlercreutz,et al. Steroid absorption and enterohepatic recycling. , 1979, Contraception.
[3] H. Breuer,et al. Measurement by isotope dilution mass spectrometry of 17 α‐ethynyloestradiol‐17 β and norethisterone in serum of women taking oral contraceptives , 1980 .
[4] A. Breckenridge,et al. Oral contraceptive steroid plasma concentrations in smokers and non-smokers. , 1981, British medical journal.
[5] K. Fotherby,et al. Interaction of ethynyloestradiol sulphate with plasma proteins. , 1980, Journal of steroid biochemistry.
[6] J. L. Hill,et al. Plasma concentrations of ethynyl oestradiol and norethindrone after oral administration to women. , 1977, Journal of reproduction and fertility.
[7] D. Mishell,et al. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. , 1977, American journal of obstetrics and gynecology.
[8] K. Carlström,et al. Ovulation inhibition with a combined oral contraceptive containing 20 micrograms ethinyl estradiol and 250 micrograms levonorgestrel. Serum levels of the active ingredients and FSH, LH, estradiol 17-beta and progesterone. , 1979, Acta obstetricia et gynecologica Scandinavica. Supplement.
[9] R. Greenblatt,et al. The metabolic clearance rate and urinary excretion of oral contraceptive drugs. II. Mestranol. , 1974, American journal of obstetrics and gynecology.
[10] A. Breckenridge,et al. Interaction of ethinyloestradiol with ascorbic acid in man. , 1981, British medical journal.
[11] K. Fotherby,et al. Metabolism of 4-14C–Ethynyl Oestradiol in Women , 1969, Nature.
[12] M. Williams,et al. The urinary metabolites of 17α-ethynylestradiol-9α,11-3H in women chromatographic profiling and identification of ethynyl and non-ethynyl compounds , 1975, Steroids.
[13] V. Laumas,et al. Radioactivity in the breast milk of lactating women after oral administration of 3H-norethynodrel. , 1967, American journal of obstetrics and gynecology.
[14] J. Goldzieher,et al. Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol. , 1980, Contraception.
[15] E. R. Plunkett,et al. Pharmacokinetics of ethynyloestradiol in women for different populations. , 1981, Contraception.
[16] A. Breckenridge,et al. Studies on the enzymatic cleavage of norethisterone oenanthate. , 1981, Contraception.
[17] K. Nygren,et al. Ethinyl estradiol in peripheral plasma after oral administration of 30μg and 50μg to women , 1978 .
[18] H. Bolt,et al. Demethylation of mestranol to ethinyloestradiol in vitro and in vivo. , 1972, Acta endocrinologica.
[19] H. Langecker. DIE METABOLITE IM MENSCHLICHEN HARN NACH VERABREICHUNG VON 17α-AETHINYL-19-NORTESTOSTERON (NORAETHISTERON) , 1961 .
[20] N. Sládek,et al. Induction of drug metabolism. I. Differences in the mechanisms by which polycyclic hydrocarbons and phenobarbital produce their inductive effects on microsomal N-demethylating systems. , 1969, Molecular pharmacology.
[21] H. A. Blair,et al. Urinary Œstrogen Metabolites of 19-Norethisterone and its Esters [Summary] , 1960, Proceedings of the Royal Society of Medicine.
[22] N. Jenkins,et al. Binding of the gestagens norethisterone and levonorgestrel in blood of various species. , 1981, Journal of steroid biochemistry.
[23] K. Laumas,et al. Quantitative analysis of norethindrone in milk using deuterated carrier and gas chromatography-mass spectrometry. , 1979, Journal of steroid biochemistry.
[24] A. Breckenridge,et al. The effect of antibiotics on the enterohepatic circulation of ethinylestradiol and norethisterone in the rat. , 1978, Journal of steroid biochemistry.
[25] R. J. Warren,et al. Plasma levels of ethynyloestradiol after administration of ethynyloestradiol or mestranol to human subjects. , 1973, The Journal of endocrinology.
[26] S. E. Morris,et al. Radioimmunoassay system for norethisterone using 3H- and 125I-labelled radioligands. , 1975, Journal of steroid biochemistry.
[27] Ethynodiol diacetate metabolites in human plasma. , 1973, The Journal of pharmacology and experimental therapeutics.
[28] M. Brozovīc,et al. An Epidemiological Study of the Haemostatic and Other Effects of Oral Contraceptives , 1976, British journal of haematology.
[29] J. Patrick,et al. Disposition of norgestimate in the presence and absence of ethinyl estradiol after oral administration to humans. , 1978, Journal of pharmaceutical sciences.
[30] L. Edqvist,et al. Peripheral plasma levels of d-norgestrel in women after oral administration of d-norgestrel and when using intravaginal rings impregnated with dl-norgestrel. , 1975, Contraception.
[31] K. Nygren,et al. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. , 1977, American journal of obstetrics and gynecology.
[32] A. Breckenridge,et al. The enzyme inducing effect of rifampicin in the rhesus monkey and its lack of interaction with oral contraceptive steroids. , 1982, Contraception.
[33] A. Hussain,et al. First-pass metabolism of ethinyl estradiol in dogs and rats. , 1981, Journal of pharmaceutical sciences.
[34] B. Ahluwalia,et al. Evidence of higher ethynylestradiol blood levels in human hypertensive oral contraceptive users. , 1977, Fertility and sterility.
[35] A. Breckenridge,et al. Reduction of the enterohepatic circulation of norethisterone by antibiotics in the rat: correlation with changes in the gut flora. , 1980, Journal of steroid biochemistry.
[36] F. Naftolin,et al. Catechol estrogen formation by the human fetal brain and pituitary. , 1976, The Journal of clinical endocrinology and metabolism.
[37] H. Breuer,et al. Wirkung von Rifampicin auf den Menstruationszyklus und die Östrogenausscheidung bei Einnahme oraler Kontrazeptiva , 1973 .
[38] W. H. Anderson,et al. Rifampin, oral contraceptives, and pregnancy. , 1976, JAMA.
[39] B. D. Kulkarni,et al. A preliminary report on urinary excretion pattern and method of isolation of 14C-ethynylestradiol metabolites in women , 1970 .
[40] E. Johansson,et al. Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. , 1976, Contraception.
[41] C. Longcope,et al. Comparison of the metabolism in dogs of estradiol-17 beta following its intravenous and oral administration. , 1980, Journal of steroid biochemistry.
[42] A. Larrañaga,et al. Clinical study of a once-a-month oral contraceptive: Quinestrol-quingestanol , 1970 .
[43] B. Saxena,et al. 'Escape' ovulation in women due to the missing of low dose combination oral contraceptive pills. , 1980, Contraception.
[44] A. Klopper,et al. Metabolism of (4-14C) norethisterone in women. , 1968, The Journal of endocrinology.
[45] G. N. Gupta,et al. Subdermal norethindrone pellets -- a method for contraception? , 1979, Contraception.
[46] D. Greenblatt,et al. Impairment of antipyrine metabolism by low‐dose oral contraceptive steroids , 1981, Clinical pharmacology and therapeutics.
[47] N. Galand,et al. Metabolism of orally administered D-norgestrel in women. , 1972, Acta endocrinologica.
[48] L. Dennerstein,et al. Plasma levels of ethinyl oestradiol and norgestrel during hormone replacement therapy. , 1980, Maturitas.
[49] R. Khurana. Estrogen-imipramine interaction. , 1972, JAMA.
[50] B. Field,et al. Inhibition of hepatic drug metabolism by noret , 1979 .
[51] B. F. Stimmel,et al. The metabolism of ethinyl estradiol in man. , 1951, The Journal of clinical endocrinology and metabolism.
[52] P. Lähteenmäki,et al. Plasma concentrations of ethinylestradiol and D-norgestrel during two immediate postabortal oral contraceptive cycles. , 1978, Contraception.
[53] D. Mishell,et al. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids. , 1978, Contraception.
[54] B. Saxena,et al. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women. , 1980, Contraception.
[55] H. Wendt,et al. Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB). , 1976, Contraception.
[56] C. Lloyd,et al. Clinical study of a once-a-month oral contraceptive: quinestrol-quingestanol. , 1970, Fertility and sterility.
[57] D. Petitti,et al. USE OF ORAL CONTRACEPTIVES, CIGARETTE SMOKING, AND RISK OF SUBARACHNOID HÆMORRHAGE , 1978, The Lancet.
[58] K. Williams. The metabolism of radioactive 17α-ethynylestradiol 3-methyl ether (mestranol) by women☆ , 1969 .
[59] K. Fotherby. Metabolism of synthetic steroids by animals and man. , 1974, Acta endocrinologica. Supplementum.
[60] R. E. Ranney. Comparative metabolism of 17alpha-ethynyl steroids used in oral contraceptives. , 1977, Journal of toxicology and environmental health.
[61] J. Annegers,et al. DO ANTICONVULSANTS REDUCE THE EFFICACY OF ORAL CONTRACEPTIVES? , 1979, Epilepsia.
[62] J. Sjövall,et al. Analysis of isomeric ethynylestradiol glucuronides in urine. , 1981, Journal of chromatography.
[63] M. Uribe,et al. Corticosteroid Pharmacokinetics in Liver Disease , 1979, Clinical pharmacokinetics.
[64] A. Sandberg,et al. Metabolic fate of ethynodiol diacetate in the baboon , 1975, Steroids.
[65] E. Diczfalusy,et al. Assessment of the specificity of norethisterone radioimmunoassays. , 1978, Journal of steroid biochemistry.
[66] E. Syvälahti,et al. RIFAMPICIN AND DRUG METABOLISM , 1974 .
[67] G. Levy,et al. Modification of drug biotransformation by vitamin C in man , 1975, Nature.
[68] A. Conney. Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.
[69] I. Kenyon. Unplanned pregnancy in an epileptic. , 1972, British medical journal.
[70] F. Stanczyk,et al. Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone. , 1980, Contraception.
[71] J. Thijssen,et al. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity. , 1975, Contraception.
[72] R. Smith,et al. Biliary excretion and hepatotoxicity of contraceptive steroids. , 1974, Acta endocrinologica. Supplementum.
[73] K. Laumas,et al. Binding of norgestrel to human plasma proteins. , 1976, Biochimica et biophysica acta.
[74] J. Crooks,et al. Impairment of human drug metabolism by oral contraceptive steroids , 1972 .
[75] J. Powell,et al. The Effect of Ampicillin on Oral Contraceptive Effectiveness , 1980, Obstetrics and gynecology.
[76] M. Meltz,et al. Variability in conjugates of ethynylestradiol produced by in vitro incubation of human liver tissue , 1977 .
[77] E. Horning,et al. Analysis of nanogram quantities of norethisterone in plasma using a GC-MS-COM selective ion detection procedure. , 1974, Steroids and lipids research.
[78] M. Orme. The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids. , 1982, British journal of clinical pharmacology.
[79] E. R. Plunkett,et al. Rate of metabolism of norethisterone in women from different populations. , 1979, Contraception.
[80] J. Chapman,et al. Metabolism of lynestrenol to norethisterone by liver homogenate. , 1970, The Journal of endocrinology.
[81] K. Fotherby,et al. Metabolism of ethynyloestradiol in man. , 1972, The Journal of endocrinology.
[82] J. K. Butler,et al. Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate. , 1979, Contraception.
[83] V. Odlind,et al. EFFECTS ON SEX HORMONE BINDING GLOBULIN OF DIFFERENT ORAL CONTRACEPTIVES CONTAINING NORETHISTERONE AND LYNESTRENOL , 1980, British journal of obstetrics and gynaecology.
[84] D. Janz,et al. Antiepileptika und die Sicherheit oraler Kontrazeptiva , 1975 .
[85] E. Johansson,et al. Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate. , 1975, Contraception.
[86] H. Bolt,et al. Irreversible protein binding of metabolites of ethynylestradiol in vivo and in vitro. , 1973, Steroids.
[87] D. Back,et al. An antibiotic interaction with ethinyloestradiol in the rat and rabbit. , 1982, Journal of steroid biochemistry.
[88] R. J. Warren,et al. Bioavailability of contraceptive steroids from capsules. , 1976, Contraception.
[89] N. Haskins,et al. Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin. , 1980, Xenobiotica; the fate of foreign compounds in biological systems.
[90] R. J. Warren,et al. Radioimmunoassay of synthetic progestogens, norethisterone and norgestrel. , 1974, The Journal of endocrinology.
[91] H. Breuer. Metabolism of progestagens. , 1970, Lancet.
[92] M. A. Johnston. General method for the assay of oral contraceptives by high-performance liquid chromatography , 1981 .
[93] K. Laumas,et al. Pharmacokinetics of norethindrone acetate in women. , 1979, American journal of obstetrics and gynecology.
[94] G. Pincus,et al. Radioactivity in the Milk of Subjects receiving Radioactive 19-Norsteroids , 1966, Nature.
[95] H. van der Molen,et al. Studies with 4-14C-lynestrenol in normal and lactating women. , 1969, Acta endocrinologica.
[96] W. Braselton,et al. Identification and measurement by gas chromatography-mass spectrometry of norethindrone and metabolites in human urine and blood. , 1977, Journal of steroid biochemistry.
[97] R. Hobkirk,et al. Metabolism of doubly labelled ethynylestradiol-3-cyclopentyl ether in women. , 1967, Steroids.
[98] A. Breckenridge,et al. Clinical implications of enzyme induction. , 1971, Annals of the New York Academy of Sciences.
[99] J. Goldzieher,et al. Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency. , 1975, American journal of obstetrics and gynecology.
[100] D. Mishell,et al. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations. , 1980, Contraception.
[101] S. Cekan,et al. On the validity of a levo-norgestrel radioimmunoassay. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[102] G. Benagiano,et al. A direct radioiodination technique for the radioimmunoassay of 17α-ethynyl, 17β-hydroxy-4-estren-3-one , 1976 .
[103] K. Gupta,et al. A study of interaction of low-dose combination oral contraceptive with Ampicillin and Metronidazole. , 1980, Contraception.
[104] A. Breckenridge,et al. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. , 1980, Contraception.
[105] R. Kropp. [Rifampicin and oral contraceptives (author's transl)]. , 1974, Praxis der Pneumologie.
[106] G. Shenfield,et al. Pregnancy attributable to interaction between tetracycline and oral contraceptives. , 1980, British medical journal.
[107] D. Riad-fahmy,et al. A Radioimmunoassay for Ethinyl Oestradiol in Plasma Incorporating an Immunosorbent, Pre-assay Purification Procedure , 1981, Annals of clinical biochemistry.
[108] P. H. Moore,et al. Specific antisera suitable for solid-phase radioimmunoassay of 11beta-hydroxyandrost-4-ene-3,17-dione. , 1974, Steroids.
[109] V. Odlind,et al. PLASMA LEVELS OF NORETHINDRONE AFTER SINGLE ORAL DOSE ADMINISTRATION OF NORETHINDRONE AND LYNESTRENOL , 1979, Clinical endocrinology.
[110] S. Somani,et al. Mechanism of estrogen-imipramine interaction. , 1973, JAMA.
[111] J. Goldzieher,et al. Antisera for radioimmunoassay of 17α-ethynylestradiol and mestranol , 1974 .
[112] W. Spellacy. A review of carbohydrate metabolism and the oral contraceptives. , 1969, American journal of obstetrics and gynecology.
[113] E. Johansson,et al. Relation between sex hormone binding globulin and D-norgestrel levels in plasma. , 1977, Acta endocrinologica.
[114] T. Luukkainen,et al. Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD. , 1982, Contraception.
[115] H. Bolt,et al. Ring A oxidation of 17alpha-ethynylestradiol in man. , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[116] D. Reimers,et al. [The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives]. , 1971, Praxis der Pneumologie.
[117] E. Johansson,et al. Plasma levels of d-norgestrel after oral administration. , 1976, Contraception.
[118] M. Briggs. Hormonal contraceptives and plasma sex hormone binding globulin. , 1975, Contraception.
[119] S. Korenman,et al. A radio-ligand binding assay system for estradiol measurement in human plasma. , 1969, The Journal of clinical endocrinology and metabolism.
[120] J. Sjövall,et al. Selective isolation procedures for GC/MS analysis of ethynyl steroids in biological material. , 1980, Journal of Steroid Biochemistry.
[121] H. Breuer,et al. Measurement of ethynyloestradiol by radioimmunoassay and by isotope dilution-mass spectrometry. , 1981, Journal of steroid biochemistry.
[122] A. Liu,et al. Urinary metabolites of DL-norgestrel in women. , 1973, Acta endocrinologica.
[123] H. Bolt. Metabolism of estrogens--natural and synthetic. , 1979, Pharmacology & therapeutics.
[124] T. Golab,et al. THE METABOLIC FATE OF ORALLY ADMINISTERED 3H-NORETHYNODREL AND 3H-NORETHINDRONE IN HUMANS. , 1963, Biochemical pharmacology.
[125] M. Hümpel,et al. Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women. , 1978, Contraception.
[126] H. Bolt,et al. Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. , 1977, Acta endocrinologica.
[127] M. Hümpel,et al. Intraindividual comparison of pharmacokinetic parameters of d-norgestrel, lynestrenol and cyproterone acetate in 6 women , 1977 .
[128] J. Goldzieher,et al. Oxidative metabolism and de-ethynylation of 17α-ethynylestradiol by baboon liver microsomes , 1977, Steroids.
[129] A. Breckenridge,et al. Kinetics of norethindrone in women; I. Radioimmunoassay and concentrations during multiple dosing , 1978, Clinical pharmacology and therapeutics.
[130] S. E. Morris,et al. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations. , 1976, Fertility and sterility.
[131] K. Fotherby,et al. Localization of norethisterone in the reproductive tract of women. , 1973, The Journal of endocrinology.
[132] A. Breckenridge,et al. The in vitro metabolism of ethinyloestradiol, mestranol and levonorgestrel by human jejunal mucosa. , 1981, British journal of clinical pharmacology.
[133] B. Sivakumar,et al. The rabbit as an animal model to study pharmacokinetics of norethindrone in women. , 1979, Contraception.
[134] M. Wall,et al. Metabolic removal of a 17-alpha-ethynyl group from the antifertility steroid, norethindrone. , 1969, The Journal of pharmacology and experimental therapeutics.
[135] H. Adlercreutz,et al. Mass spectrometric and mass fragmentographic determination of natural and synthetic steroids in biological fluids. , 1975, Journal of steroid biochemistry.
[136] K. Fotherby,et al. Bioavailability of Lynestrenol. , 1980, Arzneimittel-Forschung.
[137] C. Dollery,et al. Drug concentration in saliva , 1978, Clinical pharmacology and therapeutics.
[138] A. Breckenridge,et al. CLINICAL IMPLICATIONS OF ENZYME INDUCTION , 1971, Basic life sciences.
[139] H. van der Molen,et al. Studies with 4-14C-mestranol in lactating women. , 1969, Acta endocrinologica.
[140] V. Odlind,et al. Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone. , 1979, Contraception.
[141] N. Jenkins,et al. Binding of the contraceptive steroids norgestrel and norethisterone in human plasma. , 1980, Journal of steroid biochemistry.
[142] B. Ahluwalia,et al. Blood levels of ethynylestradiol, caffeine, aldosterone and desoxycorticosterone in hypertensive oral contraceptive users. , 1981, Contraception.
[143] A. Liu,et al. Excretion and stereoselective biotransformations of dl-, d- and l-norgestrel in women. , 1975, Drug metabolism and disposition: the biological fate of chemicals.
[144] R. Swerdloff,et al. Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women. , 1969 .
[145] J. Goldzieher,et al. Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations , 1980, Steroids.
[146] R. Greenblatt,et al. The metabolic clearance rate and urinary excretion of oral contraceptive drugs. I. Norethindrone. , 1974, American journal of obstetrics and gynecology.
[147] A. Symons,et al. Effects of neomycin on the biliary excretion and enterohepatic circulation of mestranol and 17beta-oestradiol. , 1977, Biochemical pharmacology.
[148] D. Back,et al. Drug interactions involving oral contraceptive steroid therapy. , 1984 .
[149] H. Adlercreutz. Oestrogen metabolism in liver disease. , 1970, The Journal of endocrinology.
[150] K. L. Khanna,et al. Elevated caffeine and ethynylestradiol blood levels in hypertensive oral contraceptive users. , 1977, Contraception.
[151] J. Goldzieher,et al. Metabolism of ethynyl estrogens. , 1977, Journal of toxicology and environmental health.
[152] K. Prema,et al. Pharmacokinetics of norethindrone in Indian Women. , 1979, Contraception.
[153] J. H. Tramezzani. ENRIQUE B. DEL CASTILLO 1897-1969 , 1970 .
[154] Y. Kishimoto,et al. Metabolism of oral contraceptives. I. Metabolism of ethynodiol diacetate in women. , 1972, Xenobiotica; the fate of foreign compounds in biological systems.
[155] J. Dossetor. Points from letters: Drug interaction with oral contraceptives , 1975 .
[156] J. Grudzinskas,et al. Levels of contraceptive seroids in breast milk and plasma of lactating women. , 1977, Contraception.
[157] V. Cortes-gallegos,et al. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy. , 1979, Fertility and sterility.
[158] D. Exley,et al. The determination of plasma estradiol-17 beta by competitive protein binding radioassay. , 1970, Steroids.
[159] C. Longcope,et al. The metabolism of synthetic estrogens in non-users and users of oral contraceptives , 1975, Steroids.
[160] E. Chain. The early years of the penicillin discovery , 1979 .
[161] H. Adlercreutz. Hepatic metabolism of estrogens in health and disease. , 1974, The New England journal of medicine.
[162] A. Mack,et al. Blood pressure in women taking oral contraceptives. , 1976, American heart journal.
[163] A. Breckenridge,et al. Kinetics of norethindrone in women; II. Single‐dose kinetics , 1978, Clinical pharmacology and therapeutics.
[164] H. Breuer,et al. Monitoring of the oral contraceptive 17α-ethinyloestradiol-17β in human plasma by isotopic-dilution mass spectrometry , 1978, Fortpflanzung, Besamung, und Aufzucht der Haustiere.
[165] J. Goldzieher,et al. The pharmacokinetics of ethynyl estrogens. A review. , 1977, Contraception.
[166] S. E. Morris,et al. Comparison of plasma hormone changes using a "conventional" and a "paper" pill formulation of a low-dose oral contraceptive. , 1978, Fertility and sterility.
[167] E. Johansson,et al. Effects of d-norgestrel induced decreases in sex hormone binding globulin capacity on the d-norgestrel levels in plasma , 1977 .
[168] K. Fotherby,et al. Intestinal absorption of synthetic steroids. , 1979, Journal of steroid biochemistry.
[169] T. Gallagher,et al. Estradiol metabolism in cirrhosis. , 1968, The Journal of clinical investigation.
[170] O. Bellmann,et al. ZUM STOFFWECHSEL VON NORETHISTERON (17α-ÄTHINYL-4-ÖSTREN-17β-OL-3-ON) UND DL- SOWIE D-NORGESTREL (18-METHYL-17α-ÄTHINYL-4-ÖSTREN-17β-OL-3-ON) BEIM MENSCHEN , 1971 .
[171] H. Breuer,et al. Plasma levels of norethisterone measured by radioimmunoassay and gas chromatography-mass fragmentography. , 1979, Journal of steroid biochemistry.
[172] A. Vermeulen,et al. Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptives. , 1981, Contraception.
[173] A. Breckenridge,et al. An investigation of the pharmacokinetics of ethynylestsadiol in women using badioimmunoassay , 1979 .
[174] C. Curry,et al. A competitive protein binding radioassay for 17alpha-ethynylestradiol in human plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[175] J. Goldzieher,et al. Plasma levels and pharmacokinetics of ethynyl estrogens in various populations: II. Mestranol. , 1980, Contraception.
[176] S. Murata. [Study on the metabolism of 17 alpha-ethynyl-19-nortestosterone and 17 alpha-ethynyl estrenol in vivo]. , 1968, Nihon Naibunpi Gakkai zasshi.
[177] K. Laumas,et al. Disappearance in plasma and tissue uptake of radioactivity after an intravenous injection of (6,7-3H) norethynodrel in women. , 1971, Acta endocrinologica.
[178] A. Breckenridge,et al. The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette. , 1981, Contraception.
[179] K. Fotherby,et al. Assay of ethynyloestradiol in human serum and its binding to plasma proteins. , 1980, Journal of steroid biochemistry.
[180] K. Griffiths,et al. The detection and measurement of D-norgestrel in human milk using sephadex LH 20 chromatography and radioimmunoassay , 1977, Steroids.
[181] J. Schlesselman,et al. Variation of ethinylestradiol blood levels among healthy women using oral contraceptives. , 1980, Fertility and sterility.
[182] W. Braselton,et al. Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage. , 1979, American journal of obstetrics and gynecology.
[183] E. S. Johnson,et al. Interactions between oral Yvonne contraceptives and other drugs: a review , 1976 .
[184] P. Littleton,et al. Metabolism of synthetic progestational compounds in humans. , 1968 .
[185] Y. Kishimoto,et al. Metabolism of oral contraceptives. II. Metabolism of norethynodrel in women. , 1972, Xenobiotica; the fate of foreign compounds in biological systems.
[186] A. Breckenridge,et al. First-pass effect of norethindrone in rabbits and rats. , 1978, Journal of Pharmacology and Experimental Therapeutics.
[187] M. Wall,et al. Norethynodrel metabolites in human plasma and urine. , 1972, The Journal of pharmacology and experimental therapeutics.
[188] L. Wide,et al. Inhibition of the positive feedback of oestradiol during treatment with subcutaneous implants of d-norgestrel. , 1976, Contraception.
[189] P. Littleton,et al. The identification of some human metabolites of norgestrel, a new progestational agent. , 1968, Steroids.
[190] M. Lipsett. FACTORS INFLUENCING THE RATE OF METABOLISM OF STEROID HORMONES IN MAN , 1971, Annals of the New York Academy of Sciences.
[191] N. Loudon,et al. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids. , 1982, British journal of clinical pharmacology.
[192] David C. Anderson,et al. SEX‐HORMONE‐BINDING GLOBULIN , 1974, Clinical endocrinology.
[193] D. Back,et al. PHENOBARBITONE INTERACTION WITH ORAL CONTRACEPTIVE STEROIDS IN THE RABBIT AND RAT , 1980, British journal of pharmacology.
[194] W. Braselton,et al. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration. , 1976, American journal of obstetrics and gynecology.
[195] D. Reeves,et al. Talampicillin: a new derivative of ampicillin. , 1976, British medical journal.
[196] H. M. Solomon,et al. Effect of oral contraceptives on vitamin K—dependent clotting activtiy , 1967, Clinical pharmacology and therapeutics.
[197] D. Breimer,et al. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig. , 1981, Drug metabolism and disposition: the biological fate of chemicals.
[198] D. E. Carter,et al. Effect of oral contraceptives on drug metabolism , 1974, Clinical pharmacology and therapeutics.
[199] C. Longcope,et al. Metabolism of 4-3H- and 4-14C-17α-ethynylestradiol 3-methyl ether (Mestranol) by women , 1975, Steroids.
[200] N. Jenkins,et al. Binding of the contraceptive steroids medroxyprogesterone acetate and ethynyloestradiol in blood of various species. , 1981, Journal of steroid biochemistry.
[201] P. Lundberg,et al. Induction of sex hormone binding globulin by phenytoin. , 1977, British medical journal.
[202] E. Diczfalusy,et al. Mode of action of contraceptive drugs. , 1968, American journal of obstetrics and gynecology.
[203] A. Breckenridge,et al. The pharmacokinetics of a large (3 mg) oral dose of ethynylestradiol in women. , 1980, Contraception.
[204] J. Loo,et al. Analysis of norethindrone in plasma by high-performance liquid chromatography. , 1981, Journal of liquid chromatography.
[205] A. Breckenridge,et al. The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans. , 1982, British journal of clinical pharmacology.
[206] J. Laragh,et al. Oral Contraceptives: Renin, Aldosterone, and High Blood Pressure , 1967 .
[207] K. Nygren,et al. Radioimmunoassay of norethindrone: peripheral plasma levels after oral administration to humans and rhesus monkeys. , 1974, Contraception.
[208] A. Clark,et al. Metabolic clearance rates and metabolism of mestranol and ethynylestradiol in normal young women. , 1973, Journal of Clinical Endocrinology and Metabolism.
[209] K. Carlström,et al. OVULATION INHIBITION WITH A COMBINED ORAL CONTRACEPTIVE CONTAINING 20 μg ETHINYL ESTRADIOL AND 250 μg LEVONORGESTREL , 1979 .
[210] K. Netter,et al. Atypical inductive properties of rifampicin. , 1979, Biochemical pharmacology.
[211] H. Adlercreutz,et al. In vitro metabolism of estrogens by isolated intestinal micro-organisms and by human faecal microflora. , 1980, Journal of steroid biochemistry.
[212] A. Breckenridge,et al. The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women. , 1980, Contraception.
[213] L. J. Fischer,et al. The excretion of tritium-labeled chlormadinone acetate, mestranol, norethindrone, and norethynodrel in rats and the enterohepatic circulation of metabolites. , 1974, Drug metabolism and disposition: the biological fate of chemicals.
[214] K. Williams,et al. Metabolism of radioactive 17α-ethynylestradiol by women , 1970 .
[215] A. Meli,et al. Fate of ingested radiolabeled ethynylestradiol and its 3-cyclopentyl ether in patients with bile fistulas. , 1969, The Journal of clinical endocrinology and metabolism.
[216] A. Liu,et al. The presence of dl-, d- and l-norgestrel and their metabolites in the plasma of women. , 1975, Contraception.
[217] K. J. Dennis,et al. Metabolism of [14C]norgestrel in man. , 1968, The Journal of endocrinology.
[218] F. Lucas,et al. Metabolism of norethynodre, a 19-nor progestin: subcellular localization of enzyme activity. , 1970, Steroids.
[219] A. Meli,et al. Studies on Biliary Metabolites of Orally Administered Ethynylestradiol (EE) and its 3-Cyclopentyl Ether (EECPE-Quinestrol∗) , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[220] E. Johansson,et al. Sex hormone binding globulin: the carrier protein for d-norgestrel. , 1976, The Journal of clinical endocrinology and metabolism.
[221] R. J. Mills,et al. Sex Hormone Binding Globulin: Effect of Synthetic Steroids on the Assay and Effect of Oral Contraceptives , 1981, Annals of clinical biochemistry.
[222] J. Goldzieher,et al. Human urinary and liver conjugates of 17α-ethynylestradiol , 1976, Steroids.
[223] P H Rowe,et al. The effects of ampicillin on oral contraceptive steroids in women. , 1982, British journal of clinical pharmacology.
[224] H. Gelbke,et al. Metabolism of 17alpha-ethynyl-(4-14C)oestradiol and (4-14C)mestranol in rat liver slices and interaction between 17alpha-ethynyl-2-hydroxyoestradiol and adrenalin. , 1973, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[225] G. Sankolli,et al. Influence of antisera on the estimations of norethisterone and levonorgestrel. , 1979, Journal of steroid biochemistry.
[226] H. Bolt,et al. Metabolism of 17 alpha-ethinylestradiol by human liver microsomes in vitro: aromatic hydroxylation and irreversible protein binding of metabolites. , 1974, The Journal of clinical endocrinology and metabolism.
[227] M. Danhof,et al. Therapeutic Drug Monitoring in Saliva , 1978, Clinical pharmacokinetics.
[228] K. Nygren,et al. Ethinyl estradiol in human milk and plasma after oral administration. , 1978, Contraception.
[229] J. Laragh,et al. High blood pressure and oral contraceptives. Changes in plasma renin and renin substrate and in aldosterone excretion. , 1968, American journal of obstetrics and gynecology.
[230] M. Hümpel,et al. Investigations of pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in women. , 1979, Contraception.
[231] G. Stramentinoli,et al. S-adenosyl-L-methionine antagonizes ethynylestradiol-induced bile cholesterol supersaturation in humans without modifying the estrogen plasma kinetics. , 1982, Gastroenterology.
[232] D. Mishell,et al. Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration. , 1975, Contraception.
[233] D. Hill,et al. Ethynyl cleavage of 17 alpha-ethynylestradiol in the rhesus monkey. , 1981, Drug metabolism and disposition: the biological fate of chemicals.
[234] R. N. Stillwell,et al. Characterization of metabolites of steroid contraceptives by gas chromatography and mass spectrometry. , 1972, Journal of steroid biochemistry.
[235] T. Goehl,et al. Simple high-performance liquid chromatographic assay for norethindrone--mestranol in combination tablets. , 1981, Journal of pharmaceutical sciences.
[236] K. Nygren,et al. Plasma levels of d-norgestrel and sex hormone binding globulin during oral d-norgestrel medication immediately after delivery and legal abortion. , 1977, Contraception.
[237] K. Laumas,et al. In vitro metabolism of 6,7-3H) norethynodrel in the human endometrium and the myometrium. , 1973, Acta endocrinologica.
[238] H. Bolt,et al. Retention, metabolism and elimination of 17alpha-ethynyl-estradiol-3-methyl ether (mestranol). , 1972, Xenobiotica; the fate of foreign compounds in biological systems.
[239] A. Breckenridge,et al. Plasma Xa inhibitory activities and plasma concentrations of norgestrel and ethinyloestradiol in women on oral contraceptive steroids. , 1979, British journal of clinical pharmacology.
[240] G. Tokuda,et al. CONVERSION OF SOME SYNTHETIC PROGESTINS TO OESTROGEN. , 1964, Acta endocrinologica.
[241] J. Goldzieher,et al. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol , 1975, Steroids.
[242] R. Palmer,et al. Radioimmunoassay of plasma norethisterone after ethynodiol diacetate administration. , 1977, Journal of steroid biochemistry.
[243] R. J. Warren,et al. Metabolism of D- and L-norgestrel in humans. , 1975, Arzneimittel-Forschung.